Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0001209191-21-068922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-12-09 | 2021-12-07 | RXRX | Gibson Christopher | CEO, Dir | S - Sale | $20.51 | -3,125 | 146.9K | -2% | -$64.1K |
| M | 2021-12-09 | 2021-12-07 | RXRX | Gibson Christopher | CEO, Dir | S - Sale | $20.48 | -16.7K | 8.20M | -0.2% | -$341.3K |
| 2021-12-09 | 2021-11-21 | RXRX | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | -1.10M | 8.22M | -12% | $0 | |
| MI | 2021-12-09 | 2021-11-21 | RXRX | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | +1.10M | 550.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class B Common Stock | 2021-12-07 | S | D | 3,025 | $20.49 | 146,975 | I | — | — | (F4) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.07 to $21.06 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 2 | Common | Class B Common Stock | 2021-12-07 | S | D | 1,200 | $21.06 | 8,201,216 | D | — | — | (F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $21.02 to $21.11 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 3 | Common | Class B Common Stock | 2021-12-07 | S | D | 15,467 | $20.43 | 8,202,416 | D By Gibson Family Trust | — | — | (F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.01 to $20.99 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 4 | Common | Class B Common Stock | 2021-12-07 | S | D | 100 | $21.07 | 146,875 | I | — | — | |
| 5 | Common | Class B Common Stock | 2021-11-21 | G | D | 1,100,000 | $0.00 | 8,217,883 | D By LAHWRAN-3 LLC | — | — | |
| 6 | Common | Class B Common Stock | 2021-11-21 | G | A | 550,000 | $0.00 | 550,000 | I By Gibson Family Trust | — | — | |
| 7 | Common | Class B Common Stock | 2021-11-21 | G | A | 550,000 | $0.00 | 550,000 | I By LAHWRAN-4 LLC | — | — |